Technology of Organ Regeneration Platform

Approximately 40 countries’ choice.

Combining AI, medical 3D bioprinting, one-time medical device kits.

Regenerates tissues and treats incurable chronic diseases.

Installed in hospital operating rooms.

Procedure Overview

01

Prepare the treatment site

02

Generate the site-customized 3D file with a quick and easy AI software

03

Harvest the patient’s autologous adipose tissue

04

Create printable autologus bio-ink

05

Print the patient-customized regenerative patch

06

Apply the one-time patch, priming the repair process

Dr. INVIVO
Medical bioprinter

Your Attractive Heading

Your Attractive Heading

Your Attractive Heading

Optimal result with simple

Get patient-customized regenerative patch with a touch of 3 buttons.​

Clean chamber​

Keep the environment clean and safe with built-in disinfection UV lamps.​

Streamlined with AI​

Put the innovation to practice with no need for prior knowledge of 3D modeling and slicing.​

Auto-leveling

Output of regenerative patches with ultra-precision to 10μm accuracy

Bioink dispenser replacement with quantitative output

Quantitative output for multiple syringe replacements

Patch freezing function

Additive-free solidification of regenerative patches (Prohibition of the use of medical bioglue in advanced countries)

Filament automatic loading and unloading

Automated filament loading and unloading implementation

Sterile disposable peel-off dispenser

Implement Dispenser-1 as a detachable type for contamination prevention

Remote automatic update of firmware

Remote automation of firmware updates

Remote printing telemedicine/monitoring

Remote printing telemedicine/monitoring

Medical treatment record tracking log

Troubleshooting for transmitting medical printing progress tracking log files

Optimized space-saving design

Implemented a design optimized for narrow operating rooms

User-friendliness for medical staff

Implementation of standard output for regenerative patches with just 3 button touches

Surgical process innovation

Automatic turnover modeling within 30 seconds for one image, completing the surgical process within 30 minutes

Regenerative patch shape and size accuracy 99%

Customized generation of approximately 400 sets of 3D bioprinting control settings for each tissue site to produce regenerative patches of precise, uniform, and stable quality

Video-based 3D modeling preceding research patent application

Applying the latest 3D vision AI technology, NeRF, to create 3D models of complex and highly contoured anatomical structures 20% faster and more accurately than similar technologies

Optimization of surgical costs

Minimization of outliers in 3D models with minimal computational effort, and simplification of intricate 3D model complexity through flattening technology. This leads to savings in filament and bioink costs, as well as reduced printing time

User-friendly user experience

Establishment of user-friendly and medically appropriate design through adoption of Agile development methodology for requirement gathering

Data acquisition through diverse datasets

Elimination of racial bias in data through 15-country proprietary clinical data. Augmentation of training data by 23.5 times through the application of data preprocessing pipeline. Factors including appearance/necrosis/rare tissues, race, number of photos per patient, proportion of lesion area, and lighting

Recognition of AI technology by CVPR.

The 2022 CVPR acknowledged our AI technology with an Impact Score of 63.10, a distinction for an international conference paper.

AI software

Medical Device Kit

Adipose micronizer

Tissues obtained from patients, primarily used to filter and micronize fibers from adipose tissue, with four different applications based on the processing size of the filter.

PCL (scaffold guide)

Serves as a guide for scaffold manufacturing (guiding the size and shape of the defect), removed after patch production. Made from synthetic polymer materials with biocompatibility, biodegradability, and bio absorbability properties. FDA-approved for human use.

Dispenser 1

Melting extrusion at 130 to 140 degrees Celsius for PCL.
Packaged under sterilized conditions for single-use.

Dispenser 2

Manufactured from COA material with higher strength than the conventional PP syringe material. Engineered to meet the highest quality standards for precise dosing within the syringe’s internal specifications

Bed film

A medical device material that remains uncontaminated even when in contact with bioink. Ease of removal based on the printing conditions of PCL output

Organ Regeneration Platform Protocol Video

Click here to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Get in touch

Join Now

Pages

Family Websites

Follow us

Scroll to Top